Developmental and Reproductive Toxicology
SRI’s Developmental and Reproductive Toxicology (DART) Program provides a full spectrum of pharmaceutical safety evaluation services, including studies to support preclinical development. All services are designed to comply with regulations, including Good Laboratory Practices.
Standard ICH S5(R2) Studies
Fertility, Anti-fertility, and Contraception Studies
In Vitro Screens
In Vivo Studies
For the National Institute of Mental Health (NIMH), SRI performs preclinical safety and pharmacokinetics studies for brain imaging agents and drugs to treat mental illnesses.